Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II

NCT02396459 is registered in ClinicalTrials.gov with Rare Thyroid Therapeutics International AB as lead sponsor.

NCT NCT02396459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II
Lead sponsor
Rare Thyroid Therapeutics International AB
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 7, 2020
Completion date
August 18, 2027
Enrollment
22 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

allan-herndon-dudley syndrome